Management of GI Bleeding - An IR Perspective

UChicago Medicine

D. Kumari

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

1L Therapy for HER2-, PDL1-, CLDN18.2+ Stage 4 Gastroesophageal Canc…

Hope for Stomach Cancer

D. Catenacci

Ask the Expert: The Role of Biomarkers in Stomach Cancer

Debbie's Dream Foundation

S. Klempner

Gastroenterology in Seven Decades: Some Landmarks and Reflections

MUSC Health

P. B. Cotton

ASCO® 2024 Summary: "Upper-GI Key Studies Including ESOPEC and RENAI…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, R. Mehta

ESMO Asia 2023 Insights: "Role of IO in Gastric Cancer"

Insights from 2023 ESMO Asia Annual Meeting

S. Rha

Current Surgical Management of Gastric Cancer

Total Health

N. Ikoma

ASCO GI 2023 Comparative Analysis of the Molecular Profile and Tumor…

ASCO GI 2023 Conference Coverage

A. Alqahtani

Recent Advances in the Systemic Treatment of Localized Gastroesophag…

Aysegül Ilhan-Mutlu

Esophagogastric Cancer: Case Controversies

2023 Johns Hopkins Updates in Gastrointestinal Cancers

D. Ilson, K. Bever, S. Kim, F. Johnston

Modern Radiation Therapy for Stomach Cancer: Indications and Best Pr…

Debbie's Dream Foundation

M. Chuong

Newest Advances in IO and Targeted Agents for Gastroesophageal Cancer

Debbie's Dream Foundation

D. Ilson

Minimally Invasive Gastrectomy for Gastric Cancer

Debbie's Dream Foundation

S. Khan

Year in Review 2024 - Early Stage Upper GI Cancers

Oncology 2024 Year in Review

N. Uboha

Advances in Surgery for Gastric Cancer

Debbie's Dream Foundation

M. Eskander

Targeted Therapy Approaches for Upper GI Cancer

Scripps Health

M. Strickland

Gastric Intestinal Metaplasia Surveillance: Who and How Often?

Stanford Medicine

R. J. Huang

Radiation Safety for the Endoscopist

UCSF School of Medicine

N. Hasan

1L Therapy for HER2-, PDL1-, CLDN18.2- Stage 4 Gastroesophageal Canc…

Hope for Stomach Cancer

D. Catenacci